guest ::
| Home > Publications Database > Craving induction through virtual reality cue-exposure for patients with alcohol dependence in rehabilitation treatment. > print |
| Home > Publications Database > Craving induction through virtual reality cue-exposure for patients with alcohol dependence in rehabilitation treatment. > print |
| 001 | 274054 | ||
| 005 | 20260212170758.0 | ||
| 024 | 7 | _ | |2 doi |a 10.1038/s41598-024-81071-0 |
| 024 | 7 | _ | |2 pmid |a pmid:39695314 |
| 024 | 7 | _ | |2 pmc |a pmc:PMC11655979 |
| 024 | 7 | _ | |2 altmetric |a altmetric:172236615 |
| 037 | _ | _ | |a DZNE-2025-00035 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 600 |
| 100 | 1 | _ | |a Tsamitros, N. |b 0 |
| 245 | _ | _ | |a Craving induction through virtual reality cue-exposure for patients with alcohol dependence in rehabilitation treatment. |
| 260 | _ | _ | |a [London] |b Macmillan Publishers Limited, part of Springer Nature |c 2024 |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1736341868_8154 |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 520 | _ | _ | |a New therapeutic approaches for alcohol dependence (AD) include virtual reality (VR)-based treatments offering scalable options for cue exposure (CE), a well-established strategy in cognitive behavioral therapy. This study aimed to evaluate the feasibility and tolerability of a new VR-CE paradigm. On an explorative basis, factors influencing the induction of craving were examined. This single-arm monocentric clinical study included n = 21 patients with AD in inpatient rehabilitation treatment, that completed one VR-CE session including confrontation with alcohol-associated stimuli. Measurements of subjective craving before, during and after exposure, affective states, VR side effects as cybersickness and the sense of presence in VR were conducted. Craving levels during and directly after VR-CE were significantly higher than before the intervention. Craving levels 20 min after VR-CE did not significantly differ compared to those before VR-CE. Patients described a pronounced sense of presence and only mild symptoms of cybersickness. Craving was significantly correlated with cybersickness. While positive affect decreased throughout the VR exposure, negative affect did not differ significantly in pre-post-comparisons. This study shows that craving induction through our VR-CE paradigm is feasible and well-tolerated by patients with AD in long-term rehabilitation. These results contribute to the development and future research of therapeutic VR-CE approaches. |
| 536 | _ | _ | |0 G:(DE-HGF)POF4-353 |a 353 - Clinical and Health Care Research (POF4-353) |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |2 Other |a Alcohol dependence |
| 650 | _ | 7 | |2 Other |a Craving |
| 650 | _ | 7 | |2 Other |a Cue exposure |
| 650 | _ | 7 | |2 Other |a Cybersickness |
| 650 | _ | 7 | |2 Other |a Sense of presence |
| 650 | _ | 7 | |2 Other |a Virtual reality |
| 650 | _ | 2 | |2 MeSH |a Humans |
| 650 | _ | 2 | |2 MeSH |a Alcoholism: rehabilitation |
| 650 | _ | 2 | |2 MeSH |a Alcoholism: psychology |
| 650 | _ | 2 | |2 MeSH |a Male |
| 650 | _ | 2 | |2 MeSH |a Craving |
| 650 | _ | 2 | |2 MeSH |a Female |
| 650 | _ | 2 | |2 MeSH |a Middle Aged |
| 650 | _ | 2 | |2 MeSH |a Adult |
| 650 | _ | 2 | |2 MeSH |a Cues |
| 650 | _ | 2 | |2 MeSH |a Virtual Reality |
| 650 | _ | 2 | |2 MeSH |a Virtual Reality Exposure Therapy: methods |
| 650 | _ | 2 | |2 MeSH |a Cognitive Behavioral Therapy: methods |
| 700 | 1 | _ | |a Gutwinski, S. |b 1 |
| 700 | 1 | _ | |a Beck, A. |b 2 |
| 700 | 1 | _ | |a Lange Mussons, S. |b 3 |
| 700 | 1 | _ | |a Sebold, M. |b 4 |
| 700 | 1 | _ | |a Schöneck, R. |b 5 |
| 700 | 1 | _ | |0 P:(DE-2719)2810583 |a Wolbers, T. |b 6 |u dzne |
| 700 | 1 | _ | |a Bermpohl, F. |b 7 |
| 700 | 1 | _ | |a Heinz, A. |b 8 |
| 700 | 1 | _ | |a Lütt, A. |b 9 |
| 773 | _ | _ | |0 PERI:(DE-600)2615211-3 |a 10.1038/s41598-024-81071-0 |g Vol. 14, no. 1, p. 30550 |n 1 |p 30550 |t Scientific reports |v 14 |x 2045-2322 |y 2024 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/274054/files/DZNE-2025-00035.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/274054/files/DZNE-2025-00035.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:274054 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |0 I:(DE-588)1065079516 |6 P:(DE-2719)2810583 |a Deutsches Zentrum für Neurodegenerative Erkrankungen |b 6 |k DZNE |
| 913 | 1 | _ | |0 G:(DE-HGF)POF4-353 |1 G:(DE-HGF)POF4-350 |2 G:(DE-HGF)POF4-300 |3 G:(DE-HGF)POF4 |4 G:(DE-HGF)POF |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1190 |2 StatID |a DBCoverage |b Biological Abstracts |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1040 |2 StatID |a DBCoverage |b Zoological Record |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b SCI REP-UK : 2022 |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0501 |2 StatID |a DBCoverage |b DOAJ Seal |d 2023-04-12T15:11:06Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |d 2023-04-12T15:11:06Z |
| 915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0700 |2 StatID |a Fees |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0561 |2 StatID |a Article Processing Charges |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1150 |2 StatID |a DBCoverage |b Current Contents - Physical, Chemical and Earth Sciences |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0320 |2 StatID |a DBCoverage |b PubMed Central |d 2023-08-24 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2023-08-24 |
| 920 | 1 | _ | |0 I:(DE-2719)1310002 |k AG Wolbers |l Aging, Cognition and Technology |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1310002 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|